Today: 10 April 2026
Browse Category

NASDAQ:ISRG 7 December 2025 - 11 January 2026

Why Intuitive Surgical stock (ISRG) is back in focus after Bernstein lifts its target

Why Intuitive Surgical stock (ISRG) is back in focus after Bernstein lifts its target

Intuitive Surgical shares closed Friday at $586.24, up 0.2%, after Bernstein and Goldman Sachs raised their price targets to $740 and $714, respectively. The company will present at the J.P. Morgan Healthcare Conference on Jan. 14 and report Q4 earnings Jan. 22. Investors are focused on da Vinci 5 adoption and procedure growth. The stock’s 52-week range is $425 to $616.
10 January 2026
Intuitive Surgical stock jumps as investors eye JPM healthcare conference and Jan. 22 earnings

Intuitive Surgical stock jumps as investors eye JPM healthcare conference and Jan. 22 earnings

Intuitive Surgical shares closed up 4.6% at $592.85 Tuesday and gained another 0.4% after hours. Evercore ISI raised its price target to $580, citing strong procedure and capital spending trends but kept an “In Line” rating. Trading volume reached 2.63 million shares. The company will present at the J.P. Morgan Healthcare Conference on Jan. 14 and report earnings Jan. 22.
Intuitive Surgical stock falls today: what’s driving ISRG and what investors watch next

Intuitive Surgical stock falls today: what’s driving ISRG and what investors watch next

Intuitive Surgical shares fell 1% to $560.61 in Friday’s afternoon trading, underperforming a mixed U.S. market on the first session of 2026. The move followed a management shift, with Chief Digital Officer Brian E. Miller taking a new role focused on digital and AI strategy. Medical-device stocks lagged, while broader healthcare edged higher. Investors are watching upcoming jobs and inflation data, plus the J.P. Morgan Healthcare Conference.
2 January 2026
Intuitive Surgical (ISRG) Stock: What to Know Before the Market Opens on Dec. 26, 2025

Intuitive Surgical (ISRG) Stock: What to Know Before the Market Opens on Dec. 26, 2025

Intuitive Surgical shares traded near $577.15 ahead of the Dec. 26 session after the FDA cleared expanded uses for its da Vinci SP system on Dec. 10, including hernia and gallbladder procedures. The FDA recall database lists two open Class II recalls for da Vinci 5 components, posted Dec. 19, affecting 144 units due to an ergonomic connector issue that can cause delays or require system restarts.
26 December 2025
Intuitive Surgical (ISRG) News, Analyst Forecasts and 2026 Outlook: FDA Expansion for da Vinci SP, Wall Street Targets, and What’s Next (Dec. 25, 2025)

Intuitive Surgical (ISRG) News, Analyst Forecasts and 2026 Outlook: FDA Expansion for da Vinci SP, Wall Street Targets, and What’s Next (Dec. 25, 2025)

The FDA cleared expanded indications for Intuitive Surgical’s da Vinci SP robotic system on December 10, 2025, adding inguinal hernia repair, cholecystectomy, and appendectomy. ISRG shares closed at $578 on December 24, with Q4 earnings expected in late January. Brian E. Miller will become Head of Digital and AI Strategy on January 1, 2026.
Intuitive Surgical (ISRG) Stock After Hours on Dec. 23, 2025: What’s Moving Shares and What to Watch Before the Dec. 24 Market Open

Intuitive Surgical (ISRG) Stock After Hours on Dec. 23, 2025: What’s Moving Shares and What to Watch Before the Dec. 24 Market Open

Intuitive Surgical shares closed Tuesday at $577.34, down 0.43%, and edged up 0.05% to $577.60 in after-hours trading. The S&P 500 finished near record highs as holiday trading volumes thinned. U.S. markets will close early at 1:00 p.m. ET on Wednesday, Dec. 24. Initial jobless claims data is due before the open.
Intuitive Surgical Stock (ISRG) Week Ahead: FDA da Vinci 5 Recall Posting, da Vinci SP Expansion, and Fresh Wall Street Targets Into the Christmas Trading Week

Intuitive Surgical Stock (ISRG) Week Ahead: FDA da Vinci 5 Recall Posting, da Vinci SP Expansion, and Fresh Wall Street Targets Into the Christmas Trading Week

The FDA posted a Class 2 recall for Intuitive Surgical’s da Vinci 5 console component on December 19. Days earlier, the FDA cleared da Vinci SP for use in three general surgery procedures. ISRG stock closed at $572.47 Friday, up 1.88% with trading volume nearly double its 50-day average. Shares sit about 7% below their 52-week high.
Intuitive Surgical (ISRG) Stock: Latest News, Analyst Forecasts, and 2026 Outlook (Updated Dec. 20, 2025)

Intuitive Surgical (ISRG) Stock: Latest News, Analyst Forecasts, and 2026 Outlook (Updated Dec. 20, 2025)

Intuitive Surgical shares closed at $572.47 on Friday, Dec. 19, up 1.88% after the FDA cleared its da Vinci SP system for three new procedures. The stock rebounded from mid-December lows and gained 1.75% over the month. Analysts raised price targets toward $650 heading into 2026. Investors are watching for further adoption of the single-port platform.
21 December 2025
Intuitive Surgical Stock (ISRG) News Today: Price Action, Analyst Forecasts, and What to Watch on December 16, 2025

Intuitive Surgical Stock (ISRG) News Today: Price Action, Analyst Forecasts, and What to Watch on December 16, 2025

Intuitive Surgical shares fell about 2% to $548–$549 in late morning trading Tuesday, following a 3.17% rebound Monday that ended a five-day losing streak. The company’s market cap stood near $194 billion. Technical analysts noted the stock’s Relative Strength Rating rose to 81. Recent SEC filings showed mixed institutional activity, with Orion Portfolio Solutions increasing its stake and Nilsine Partners reducing holdings.
16 December 2025
Intuitive Surgical (ISRG) Stock News Today: What’s Driving Shares, Latest Analyst Forecasts, and Key Catalysts for 2026 (Dec. 15, 2025)

Intuitive Surgical (ISRG) Stock News Today: What’s Driving Shares, Latest Analyst Forecasts, and Key Catalysts for 2026 (Dec. 15, 2025)

Intuitive Surgical shares rose about 3% to near $558 on Dec. 15, 2025, amid heavy institutional-filing headlines and options market activity. SevenBridge Financial Group boosted its ISRG stake by 68.6%, while Silicon Valley Capital Partners cut its position by 96.5%. Texas Permanent School Fund and Neville Rodie & Shaw also trimmed holdings. Corient Private Wealth increased its stake by 68.8%.
15 December 2025
Intuitive Surgical Stock News: ISRG Drops ~4% This Week Despite FDA Clearance, Citi Downgrade, and New Price Targets (Updated Dec. 12, 2025)

Intuitive Surgical Stock News: ISRG Drops ~4% This Week Despite FDA Clearance, Citi Downgrade, and New Price Targets (Updated Dec. 12, 2025)

Intuitive Surgical shares fell 4.3% this week, closing at $542.32 Friday after five straight declines. The drop followed FDA clearance expanding da Vinci SP’s U.S. indications, a Citigroup downgrade, a Wells Fargo price-target hike, and insider selling disclosures. ISRG now trades about 12% below its 52-week high.
13 December 2025
Intuitive Surgical (ISRG) Stock After Hours on Dec. 12, 2025: Wells Fargo Raises Target, Insider Filing Surfaces—What to Know Ahead of the Next Market Open

Intuitive Surgical (ISRG) Stock After Hours on Dec. 12, 2025: Wells Fargo Raises Target, Insider Filing Surfaces—What to Know Ahead of the Next Market Open

Intuitive Surgical (ISRG) closed Friday, Dec. 12, 2025, at $542.32, down 0.92%, with after-hours trading flat near $542.00. Shares moved between $537.70 and $548.93 on volume of 2.08 million. Wells Fargo raised its price target to $654 and kept an Overweight rating. U.S. markets are closed Saturday; next regular session is Monday.
13 December 2025
Intuitive Surgical (ISRG) Stock After Hours Dec. 12, 2025: Citi Downgrade, Wells Fargo Price Target Raise, Insider Filing — What to Know Before the Next Market Open

Intuitive Surgical (ISRG) Stock After Hours Dec. 12, 2025: Citi Downgrade, Wells Fargo Price Target Raise, Insider Filing — What to Know Before the Next Market Open

Intuitive Surgical closed Friday at $542.32, down 0.92%, then traded nearly flat after hours. The stock moved amid a Citigroup downgrade to Neutral with a $635 target and a Wells Fargo target hike to $654. VP Mark Brosius filed to sell 5,276 shares under a 10b5-1 plan. Quantinno increased its stake, according to MarketBeat.
13 December 2025
Intuitive Surgical (ISRG) Stock on December 7, 2025: Earnings Beat, Da Vinci 5 Momentum and What Wall Street Expects Next

Intuitive Surgical (ISRG) Stock on December 7, 2025: Earnings Beat, Da Vinci 5 Momentum and What Wall Street Expects Next

Intuitive Surgical shares closed at $575.34 on December 5, up 1.18%, near the top of their 52-week range. CalPERS raised its stake by 7% in Q2, while Executive Chair Gary Guthart sold $13 million in stock on December 1. Trading volume was light, but ISRG outperformed medtech peers. Some analysts describe the stock’s technical outlook as neutral.
7 December 2025

Stock Market Today

  • U.S. Stocks Rally as Middle East Ceasefire Talks Boost Market Sentiment
    April 9, 2026, 7:38 PM EDT. U.S. stocks continued a strong run with the S&P 500 and Nasdaq extending their winning streaks to seven sessions, buoyed by optimism around ceasefire talks in the Middle East. The Philadelphia Semiconductor Index hit a record high, supported by gains from Amazon, Intel, Nike, and Brown-Forman. Oil prices rose modestly, settling near $98 a barrel amid tight supply concerns and restrictions on the Strait of Hormuz, a key oil shipping route. Bitcoin broke above $72,000, reflecting broader risk appetite. Market attention remains fixed on whether the ceasefire and direct Israel-Lebanon negotiations can be sustained, with U.S. Treasury yields largely unchanged. Analysts caution the S&P 500's 6,800 level is pivotal, noting sentiment balances positive headlines with skepticism. The memory sector's rally continues, and options data signals key technical support levels for market stability.

Latest article

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

9 April 2026
Meta Platforms signed a new $21 billion deal with CoreWeave for AI cloud computing capacity through 2032, according to a securities filing. CoreWeave shares rose 3.4% in after-hours trading. The agreement adds to a $14.2 billion commitment disclosed last September. CoreWeave also launched $3 billion in convertible notes and upsized a senior-notes deal to $1.75 billion.
Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

9 April 2026
Tesla is developing a lower-cost compact SUV, with initial production planned for Shanghai, Reuters reported Thursday. The company built 408,386 vehicles and delivered 358,023 in the first quarter, leaving its widest gap in at least four years. Reuters said the new SUV likely will not reach production this year. Tesla did not respond to questions about the project.
NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

9 April 2026
NIO opened pre-orders for its ES9 flagship SUV Thursday, pricing it at 528,000 yuan with battery or 420,000 yuan under its Battery-as-a-Service plan. March deliveries rose 136% year-on-year, but NIO’s U.S. shares fell 4.9% after the announcement. The ES9 enters a shrinking premium SUV market in China, competing with Li Auto and Aito. CEO William Li warned chip shortages could add up to 10,000 yuan per vehicle.
Plug Power Stock Climbs After 2026 Profit Push, Up to $200M Cost-Cut Plan

Plug Power Stock Climbs After 2026 Profit Push, Up to $200M Cost-Cut Plan

9 April 2026
Plug Power shares rose 2.5% to $2.715 Thursday after the company reaffirmed its target of positive EBITDAS by end-2026 and projected up to $200 million in savings from Project Quantum Leap. The update followed a major electrolyzer project win in Quebec and investor meetings in Toronto and Montreal. Plug reported 2025 revenue of $710 million and a fourth-quarter gross profit of $5.5 million.
Go toTop